| 英文名称 | 中文名称 | CAS | MF |
|
(R)-2-HYDROXYBUTYRIC ACID
|
|
|
C4H8O3
|
|
22(R)-hydroxydesmosterol
|
|
54604-98-7
|
C27H44O2
|
|
(4R)-4-(2-HYDROXYETHYL)-2-PHENYL-1,3-DIOXOLANE
|
(4R)-4-(2-HYDROXYETHYL)-2-PHENYL-1,3-DIOXOLANE
|
187102-96-1
|
C11H14O3
|
|
20R-INOKOSTERONE
|
|
|
C27H44O7
|
|
rHyFilaggrin
|
|
|
|
|
Rin protein (GTPase)
|
|
|
|
|
RIOHAIRNATURALIZERSYSTEM
|
|
|
|
|
RIN1(RASINHIBITOR),~100KDAND35KD,GOATANTI-HUMAN:WB
|
|
|
|
|
RIP
|
H-Tyr-Ser-Pro-Trp-Thr-Asn-Phe-OH
|
228544-21-6
|
C45H55N9O12
|
|
RINSE SOLUTION
|
|
|
|
|
RIPA Buffer Concentrate
|
|
|
|
|
RIPA BUFFER
|
蛋白提取细胞裂解缓冲液
|
|
|
|
RINT-1 protein, human
|
|
|
|
|
Ripaglinide
|
|
|
|
|
riparin
|
riparin
|
112356-54-4
|
C16H17NO4
|
|
RI PBLUESCRIPT(R) II RI PREDIGESTED VECTORS
|
|
|
|
|
Ripazepam
|
利帕西泮
|
26308-28-1
|
C15H16N4O
|
|
rhynchonin B
|
|
|
|
|
rhynchotechol
|
化合物 T34322
|
133086-78-9
|
C17H14O6
|
|
rhynchonin A
|
|
|
|
|
Rhynchophylline
|
钩藤碱
|
76-66-4
|
C22H28N2O4
|
|
R-(+)-Hyoscyamine
|
(+)-莨菪碱
|
13269-35-7
|
C17H23NO3
|
|
RIPE SWEET TOMATO
|
|
|
|
|
RIOPROSTIL
|
利奥前列素
|
77287-05-9
|
C21H38O4
|
|
RIPIDOLITE
|
|
|
|
|
Riot Control Agents, Chemical
|
|
|
|
|
Ripinirole HCL
|
|
|
|
|
Ripisartan
|
利匹沙坦
|
148504-51-2
|
C23H22N8O
|
|
Rip1 peroxidase
|
|
|
|
|
ripostatin A
|
|
|
|
|
ripostatin B
|
|
157676-95-4
|
C30H40O6
|
|
Ripple filler
|
波纹填料
|
|
|
|
RIP60 protein
|
|
|
|
|
RIP1 protein, yeast
|
|
|
|
|
RIP2 protein
|
|
|
|
|
RIP3(RECEPTORINTERACTINGPROTEIN3),RABBITANTI-MOUSE,RAT:WB
|
|
|
|
|
Rir1a protein
|
|
|
|
|
RK-397
|
红放线菌素A
|
154396-73-3
|
C35H56O10
|
|
RK-682
|
TAN 1364B
|
154639-24-4
|
C21H36O5
|
|
RisA protein
|
|
|
|
|
RISBZ1 protein
|
|
|
|
|
Risedremate Sodium
|
利噻膦酸钠
|
329003-65-8
|
C7H14NNaO8P2
|
|
Risedronic Acid Monoethyl Ester
|
Risedronic Acid Monoethyl Ester
|
1246815-73-5
|
C9H15NO7P2
|
|
Risedronate Related Compound B (20 mg) ([3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt)
|
Risedronate Related Compound B (20 mg) ([3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt)
|
|
|
|
RISEDRONIC ACID-D4
|
|
|
C7H7D4NO7P2
|
|
Risedronic acid
|
利塞膦酸
|
105462-24-6
|
C7H11NO7P2
|
|
RisedronateSodium[1-Hydroxy-2-(3-Pyrikdinyl)Ethyudene]BisphosPhonicAcid
|
|
|
|
|
Risedronate Sodium Monohydrate
|
|
|
|
|
Risedronate Acid
|
|
|
|
|
Risedronic Acid-d6
|
|
|
|
|
Risedronic Acid-d4 (major)
|
|
|
C7H11NO7P2
|
|
Sodium risedronate
|
利塞膦酸钠
|
115436-72-1
|
C7H12NNaO7P2
|
|
RISDRONATE SODIUM
|
|
|
C7H10NNaO7P2
|
|
(-)-Rishitin
|
|
18178-54-6
|
C14H22O2
|
|
Rishitinol
|
|
31316-42-4
|
C15H22O2
|
|
Rishitin
|
|
59545-99-2
|
C14H22O2
|
|
rishirilide A
|
RISHIRILIDE A
|
93361-65-0
|
C21H24O7
|
|
Rising and falling film absorber
|
升降膜式吸收器
|
|
|
|
Rising-falling film evaporator
|
升降膜式蒸发器
|
|
|
|
RISK-1
|
|
|
|
|
RISKASSESSMENTOFCARCINOGENICITY
|
|
|
|
|
RISKASSESSMENT(CONTACTDERMATITIS)
|
|
|
|
|
RISKASSESSMENTFORCHILDREN
|
|
|
|
|
RISKASSESSMENTFORELDERLY
|
|
|
|
|
RISKASSESSMENT
|
|
|
|
|
RISKANALYSIS
|
|
|
|
|
RISKASSESSMENT(NUTRIENTS)
|
|
|
|
|
RISKASSESSMENT(GENERAL)
|
|
|
|
|
RISKASSESSMENTOFCARCINOGENS
|
|
|
|
|
RISKBENEFITANALYSIS
|
|
|
|
|
RitaExtract
|
|
|
|
|
Ritalinic Acid-d10
Discontinued
|
|
|
C13H7D10NO2
|
|
Ritalinic-d9 Acid HCl
|
|
|
|
|
Ritalinic acid
|
α-苯基哌啶基-2-乙酸
|
19395-41-6
|
C13H17NO2
|
|
Ritalinic Acid-d10
|
|
|
C13H17NO2
|
|
Ritalinic Acid-d10 Hydrochloride Salt
|
|
|
C13H8D10ClNO2
|
|
Ritalin
|
匹普鲁多
|
113-45-1
|
C14H19NO2
|
|
RISKMANAGEMENT
|
|
|
|
|
Ritanserin
|
利坦丝林
|
87051-43-2
|
C27H25F2N3OS
|
|
RITANSERIN, FREE BASE OR L-TARTRATE SALT
|
|
|
|
|
RITA protein
|
|
|
|
|
RISKRANKING
|
|
|
|
|
RISKREDUCTION
|
|
|
|
|
Rita/SoapNut
|
|
|
|
|
RITC-DEXTRAN
|
罗丹明B异硫氰酸酯标记葡聚糖
|
|
|
|
RIT-CIZER NO 9
|
|
|
|
|
Rismorelin
|
利莫瑞林
|
|
|
|
R-2-ISOBUTYL-PIPERAZINE-2HCl
|
R-2-异丁基-哌嗪盐酸盐
|
853730-57-1
|
C8H18N2
|
|
R-2-Isobutyl-1,2,3,4-tetrahydro-quinoline
|
|
1115387-00-2
|
C13H19N
|
|
R-Isobutyl-D-cysteine
|
|
|
C7H15NO2S
|
|
[R,(+)]-3-Isobutyl-5-methyl-2,3-hexanediol
|
|
|
C11H24O2
|
|
R-4-Isobutyl-2-Oxazolidone
|
|
|
C7H13NO2
|
|
(R)-3-Isobutylmorpholine
|
(R)-3-异丁基吗啉
|
711014-40-3
|
C8H17NO
|
|
(R)-(-)-2-isobutylsuccinic acid 4-methyl ester
|
|
|
C9H16O4
|
|
(R)-4-ISOBUTYL-2-OXAZOLIDINONE
|
|
|
C7H13NO2
|
|
(R)-1-(4-ISOBUTYLPHENYL)ETHANAMINE
|
1212142-57-8
|
1212142-57-8
|
C12H19N
|
|
(R)-4-ISOBUTYL-OXAZOLIDINE-2,5-DIONE
|
(R)-4-异丁基噁唑烷-2,5-二酮
|
51018-87-2
|
C7H11NO3
|
|
(R)-6-ISOBUTYL-PIPERAZIN-2-ONE
|
|
|
C8H16N2O
|
|
(R)-3-ISOBUTYL-PIPERAZIN-2-ONE
|
|
|
C8H16N2O
|
|
(4R)-4-Isobutyl-2-oxazolidinone
|
(R)-4-异丁基噁唑啉-2-酮
|
161106-42-9
|
C7H13NO2
|